OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
WINE55

PT Hatten Bali PT Tbk

Food Retail & DistributionVerified

The company's capital structure is characterized by a debt-to-equity ratio of 0.42, indicating a relatively conservative leverage position compared to industry norms. However, the liquidity risk is assessed as medium, with a negative net cash position after subtracting total debt. Free cash flow stands at 6.76 billion IDR, while operating cash flow is negative at -18.99 billion IDR, suggesting operational inefficiencies or high working capital requirements. Profitability metrics show a return on equity (ROE) of 3.56% and a return on assets (ROA) of 2.32%. These figures are below the typical thresholds for high-performing retailers, indicating that the company is not generating strong returns relative to its equity and asset base. Gross profit of 30.1 billion IDR and operating income of 17.5 billion IDR suggest a moderate level of profitability, but the net income of 9.98 billion IDR is relatively low given the company's asset size. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment-specific data limits the ability to assess the performance of different parts of the business. Looking ahead, the company's growth trajectory is uncertain. Historical revenue data is not provided, but the current financial performance does not suggest strong growth momentum. The capital expenditure of -11.36 billion IDR indicates a reduction in investment, which may signal a strategic shift or financial constraints. The outlook for the next fiscal year remains unclear without additional guidance. Risk factors include medium liquidity risk and low dilution potential. The company's negative net cash position after subtracting total debt is a key flag, indicating potential challenges in meeting short-term obligations. No significant dilution sources are identified, and the dilution near-term probability is assessed as low. Recent events include the latest financial filing, which provides the most recent snapshot of the company's financial health. No recent earnings call transcripts or significant corporate actions are disclosed, limiting the visibility into management's strategic direction and operational performance.

30-day price · WINE+1.00 (+0.6%)
Low$173.00High$189.00Close$179.00As of13 May, 00:00 UTC
Profile
CompanyPT Hatten Bali PT Tbk
TickerWINE.JK
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. PT Hatten Bali PT Tbk operates in the food retail and distribution sector, generating revenue primarily through the sale of food and drug products in Indonesia.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a confidence level of 0.92.

The company's capital structure is characterized by a debt-to-equity ratio of 0.42, indicating a relatively conservative leverage position compared to industry norms. However, the liquidity risk is assessed as medium, with a negative net cash position after subtracting total debt. Free cash flow stands at 6.76 billion IDR, while operating cash flow is negative at -18.99 billion IDR, suggesting operational inefficiencies or high working capital requirements. Profitability metrics show a return on equity (ROE) of 3.56% and a return on assets (ROA) of 2.32%. These figures are below the typical thresholds for high-performing retailers, indicating that the company is not generating strong returns relative to its equity and asset base. Gross profit of 30.1 billion IDR and operating income of 17.5 billion IDR suggest a moderate level of profitability, but the net income of 9.98 billion IDR is relatively low given the company's asset size. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment-specific data limits the ability to assess the performance of different parts of the business. Looking ahead, the company's growth trajectory is uncertain. Historical revenue data is not provided, but the current financial performance does not suggest strong growth momentum. The capital expenditure of -11.36 billion IDR indicates a reduction in investment, which may signal a strategic shift or financial constraints. The outlook for the next fiscal year remains unclear without additional guidance. Risk factors include medium liquidity risk and low dilution potential. The company's negative net cash position after subtracting total debt is a key flag, indicating potential challenges in meeting short-term obligations. No significant dilution sources are identified, and the dilution near-term probability is assessed as low. Recent events include the latest financial filing, which provides the most recent snapshot of the company's financial health. No recent earnings call transcripts or significant corporate actions are disclosed, limiting the visibility into management's strategic direction and operational performance.
Key takeaways
  • The company maintains a conservative debt-to-equity ratio of 0.42, but faces medium liquidity risk due to a negative net cash position.
  • ROE and ROA are below industry benchmarks, indicating suboptimal returns on equity and assets.
  • Revenue is concentrated in a single segment with no geographic diversification, increasing exposure to regional risks.
  • Capital expenditure has declined, suggesting a potential strategic shift or financial constraints.
  • No significant dilution sources are identified, and the dilution near-term probability is low.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue$68.65B
Gross profit$30.10B
Operating income$17.46B
Net income$9.98B
R&D
SG&A
D&A
SBC
Operating cash flow-$18.99B
CapEx-$11.36B
Free cash flow$6.76B
Total assets$429.46B
Total liabilities$149.37B
Total equity$280.09B
Cash & equivalents
Long-term debt$116.91B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$82.07B$284.4M-$8.71B-$6.75B
FY-3$189.39B$41.49B$21.24B$21.30B
FY-2$253.68B$58.41B$39.62B$31.48B
FY-1$283.83B$69.73B$44.79B$27.66B
FY0$285.76B$55.57B$39.52B$31.89B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$266.25B$123.08B$3.68B
FY-3$303.34B$148.06B$9.17B
FY-2$384.46B$265.45B$16.92B
FY-1$451.38B$305.28B
FY0$452.84B$337.05B
PeriodOCFCapExFCFSBC
FY-4-$23.14B-$1.68B-$6.75B
FY-3$1.57B-$3.50B$21.30B
FY-2-$16.83B-$8.55B$31.48B
FY-1$881.4M-$18.47B$27.66B
FY0$61.41B-$6.91B$31.89B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$68.65B$17.46B$9.98B$6.76B
FQ-6$86.19B$23.71B$16.59B$14.59B
FQ-5$74.26B$14.32B$7.19B$5.03B
FQ-4$57.65B$12.10B$8.00B$7.20B
FQ-3$73.09B$15.00B$9.92B$10.25B
FQ-2$84.80B$20.61B$14.89B$17.02B
FQ-1$70.18B$7.83B$6.71B$5.96B
FQ0$58.21B$9.05B$5.25B$5.29B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$429.46B$280.09B
FQ-6$429.45B$296.68B
FQ-5$451.38B$305.28B
FQ-4$445.19B$313.28B
FQ-3$448.27B$313.71B
FQ-2$461.05B$328.61B
FQ-1$452.84B$337.05B
FQ0$447.47B$342.30B
PeriodOCFCapExFCFSBC
FQ-7-$18.99B-$11.36B$6.76B
FQ-6-$339.9M-$14.82B$14.59B
FQ-5$881.4M-$18.47B$5.03B
FQ-4-$342.9M-$1.39B$7.20B
FQ-3$16.56B-$2.62B$10.25B
FQ-2$43.56B-$2.11B$17.02B
FQ-1$61.41B-$6.91B$5.96B
FQ0$9.11B-$2.32B$5.29B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$280.09B
Net cash-$116.91B
Current ratio2.8
Debt/Equity0.4
ROA2.3%
ROE3.6%
Cash conversion-1.9%
CapEx/Revenue-16.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricWINEActivity
Op margin25.4%3.1% medp25 1.2% · p75 6.8%top quartile
Net margin14.5%2.0% medp25 0.7% · p75 4.1%top quartile
Gross margin43.8%26.1% medp25 17.2% · p75 32.0%top quartile
CapEx / revenue-16.6%-2.5% medp25 -4.6% · p75 -1.4%bottom quartile
Debt / equity42.0%56.0% medp25 16.8% · p75 121.1%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 06:06 UTC#2ecc081d
Source: analysis-pipeline (hybrid)Generated: 2026-05-30 00:54 UTCJob: fc4164a2